Abstract
We probed the mechanism by which the Parkinsons disease-associated protein α–synuclein (α–syn)/SNCApromotes the pathogenesis and progression of melanoma. We found that the human melanoma cell line SK–MEL–28 in whichSNCAis knocked out (SNCA-KO) has low levels of tetraspanin CD81, which is a cell-surface protein that promotes invasion, migration, and immune suppression. Analyzing data from the Cancer Genome Atlas, we show thatSNCAandCD81mRNA levels are positively correlated in melanoma; melanoma survival is inversely related to the levels ofSNCAandCD81; andSNCA/CD81are inversely related to the expression of key cytokine genes (IL12A,IL12B,IFN,IFNG,PRF1andGZMB) for immune activation and immune cell-mediated killing of melanoma cells. We propose that high levels of α–syn and CD81 in melanoma and in immune cells drive invasion and migration and in parallel cause an immunosuppressive microenvironment; these contributing factors lead to aggressive melanomas.
Publisher
Cold Spring Harbor Laboratory
Reference48 articles.
1. Parkinson's disease
2. Hallmarks of Cancer: The Next Generation
3. Parkinson’s disease and cancer: a systematic review and meta-analysis on the influence of lifestyle habits, genetic variants, and gender;Joon Yan Selene Lee, J. H. N., Seyed Ehsan Saffari, Eng-King Tan;Aging (Albany NY),2022
4. Family history of melanoma and Parkinson disease risk
5. Parkinson’s disease and cancer risk: a systematic review and meta-analysis